It reduces glucose production in the liver, decreases intestinal glucose absorption, and enhances insulin sensitivity in body tissues [15]
Here is exactly how to navigate each
Dosing starts low, typically 0.25 mg weekly, and titrates upward over the first few months toward a steady maintenance dose of up to 2.4 mg, paced to your tolerance
Studies tracking metabolic panels in GLP-1 users show shifts in energy expenditure patterns, though the magnitude varies based on individual genetic factors, baseline body composition, and treatment duration
This data reveals whether your genetic profile will benefit from semaglutide alone, dual-compound GLP-Squared therapy, or strategic inositol supplementation, enabling your clinician to build a truly personalized protocol rather than relying on one-size-fits-all approaches
Code availability Source code for SpaMTP is available on GitHub ( Documentation and tutorials used to generate all figures in this publication are available through the SpaMTP website ( References Alexandrov, T